You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-risk coronary artery disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease Trial in Seoul (Invasive coronary angiography, Non-invasive functional test)

Not yet recruiting
  • Coronary Artery Disease
  • Invasive coronary angiography
  • Non-invasive functional test
  • Seoul, Korea, Republic of
    Samsung Medical Center
Apr 4, 2023

Coronary Heart Disease Trial in Beijing (Ticagrelor, Clopidogrel, Aspirin)

Not yet recruiting
  • Coronary Heart Disease
  • Beijing, Beijing, China
    Fuwai Hospital
Oct 15, 2023

Pressure-Volume Loop During High-Risk PCI

Recruiting
  • Coronary Artery Disease
  • High-risk percutaneous coronary intervention
  • Detroit, Michigan
    Henry Ford Hospital
Dec 6, 2022

Coronary Artery Disease Trial (Routine Angiography Follow-up, Routine Clinical Follow-up)

Not yet recruiting
  • Coronary Artery Disease
  • Routine Angiography Follow-up
  • Routine Clinical Follow-up
  • (no location specified)
Jun 20, 2023

Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)

Not yet recruiting
  • Coronary Artery Disease
  • Clopidogrel monotherapy
  • Tailored anti-platelet therapy
  • Seoul, Korea, Republic of
    Severance Hospital
Jul 3, 2023

Coronary Atherosclerosis Due to Calcified Coronary Lesion Trial (Non-invasive stress test, Medical treatment without further

Not yet recruiting
  • Coronary Atherosclerosis Due to Calcified Coronary Lesion
  • Non-invasive stress test
  • Medical treatment without further testing
  • (no location specified)
Mar 21, 2023

Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor

Not yet recruiting
  • Dual Antiplatelet Therapy
  • +2 more
  • P2Y12 inhibitor de-escalation
  • Messina, Italy
  • +1 more
Jun 12, 2023

IHD, LV Dysfunction Trial in Copenhagen (PCI, CABG)

Not yet recruiting
  • IHD
  • LV Dysfunction
  • PCI
  • CABG
  • Copenhagen, Denmark
    Rigshospitalet, University of Copenhagen
Sep 11, 2022

Coronary Artery Disease, High Bleeding Risk Patients Trial (BioFreedom Ultra)

Not yet recruiting
  • Coronary Artery Disease
  • High Bleeding Risk Patients
  • BioFreedom Ultra
  • (no location specified)
Dec 7, 2022

Coronary Artery Disease Trial in Xi'an (Hydroxychloroquine Sulfate Tablets, Placebo Tablets)

Completed
  • Coronary Artery Disease
  • Hydroxychloroquine Sulfate Tablets
  • Placebo Tablets
  • Xi'an, Shanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 26, 2021

Coronary Artery Disease Trial in Seoul (Percutaneous coronary intervention)

Recruiting
  • Coronary Artery Disease
  • Percutaneous coronary intervention
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 6, 2022

Intravenous CAngrelor in High-bleeding Risk Patients Undergoing

Recruiting
  • Bleeding
  • +2 more
  • Caserta, Italy
  • +1 more
Aug 11, 2022

Drug-eluting Stent, Coronary Artery Disease Trial in Yongin (Genoss DES)

Recruiting
  • Drug-eluting Stent
  • Coronary Artery Disease
  • Genoss DES
  • Yongin, Gyeonggi-do, Korea, Republic of
    Yongin Severance Hospital
Jul 2, 2022

Atheroscleroses, Coronary Trial in Amsterdam (68Ga-Dotatate PET/CT)

Recruiting
  • Atheroscleroses, Coronary
  • 68Ga-Dotatate PET/CT
  • Amsterdam, Netherlands
    Academic Medical Center
Sep 8, 2022

Coronary Artery Disease, Coronary Syndrome, Cryotherapy Effect Trial in Tbilisi (CryoTherapy System (CTS))

Active, not recruiting
  • Coronary Artery Disease
  • +5 more
  • CryoTherapy System (CTS)
  • Tbilisi, Georgia
    Israeli-Georgian Research Clinic Helsicore
Nov 30, 2022

Coronary Artery Disease Trial in Nanjing (IVUS guidance, Angiography guidance)

Recruiting
  • Coronary Artery Disease
  • IVUS guidance
  • Angiography guidance
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Jun 26, 2022

Acute Coronary Syndrome, Ischemic Heart Disease Trial in Shanghai, Seoul (CCTA-derived high risk plaque characteristics,

Active, not recruiting
  • Acute Coronary Syndrome
  • Ischemic Heart Disease
  • CCTA-derived high risk plaque characteristics
  • CFD-derived hemodynamic parameters
  • Shanghai, China
  • +1 more
Sep 6, 2022

Coronary Artery Disease Trial

Not yet recruiting
  • Coronary Artery Disease
    • (no location specified)
    May 7, 2022

    Coronary Artery Disease (CAD), Peripheral Arterial Disease (PAD) Trial in Netherlands (Rivaroxaban 2.5 MG [Xarelto])

    Active, not recruiting
    • Coronary Artery Disease (CAD)
    • Peripheral Arterial Disease (PAD)
    • Rivaroxaban 2.5 MG [Xarelto]
    • Amsterdam, Netherlands
    • +11 more
    Sep 27, 2022

    Ischemic Heart Disease, Coronary Artery Disease Trial in London (Percutaneous left ventricular unloading)

    Recruiting
    • Ischemic Heart Disease
    • Coronary Artery Disease
    • Percutaneous left ventricular unloading
    • London, United Kingdom
      Guy's and St Thomas' NHS Foundation Trust
    Aug 3, 2022

    Coronary Artery Disease Trial in Nijmegen (Extracorporeal Membrane Oxygenation)

    Completed
    • Coronary Artery Disease
    • Extracorporeal Membrane Oxygenation
    • Nijmegen, Netherlands
      Radboud University Medical Centre
    May 20, 2022

    Coronary Artery Disease Trial in Qingdao (Colchicine, Placebo)

    Not yet recruiting
    • Coronary Artery Disease
    • Qingdao, Shandong, China
      Mengmei Li
    Mar 6, 2022

    Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

    Recruiting
    • Coronary Artery Disease
    • Coronary CTA
    • Shanghai, China
      Shanghai Zhongshan Hospital
    Apr 4, 2022

    Myocardial Infarction, Coronary Artery Disease Trial in Giessen (Preoperative IABC)

    Withdrawn
    • Myocardial Infarction
    • Coronary Artery Disease
    • Preoperative IABC
    • Giessen, Germany
      Department of Adult and Pediatric Cardiovascular Surgery
    Nov 12, 2021

    Coronary Artery Disease, Atherosclerotic Plaque Trial in Los Angeles (18F-NaF PET and coronary CTA imaging)

    Completed
    • Coronary Artery Disease
    • Atherosclerotic Plaque
    • 18F-NaF PET and coronary CTA imaging
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jul 20, 2022